Adiponectin in children on peritoneal dialysis: Relationship to insulin resistance and nutritional status

Nephron - Clinical Practice

Volumn 113, Issue 1, 2009, Pages

  Kamariski, Mariana ^a,b   Biscardi, Mónica ^b   Cestino, Laura ^b   Miatello, Roberto ^a   Guntsche, Enrique ^b   Valles, Patricia G ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Hospital H Notti   (Argentina)

Author keywords

Adiponectin, children; Chronic kidney disease; Continuous ambulatory peritoneal dialysis; Insulin resistance; Nutritional status; Oral glucose tolerance testing; Peritoneal dialysis

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; RESISTIN;

ADOLESCENT; ARTICLE; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHILD; CHILD NUTRITION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NUTRITIONAL STATUS; ORAL GLUCOSE TOLERANCE TEST; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SCHOOL CHILD; SCORING SYSTEM; SKINFOLD THICKNESS;

ADIPONECTIN; ADIPOSE TISSUE; ADOLESCENT; ANTHROPOMETRY; BODY COMPOSITION; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MALNUTRITION; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RESISTIN; WASTING SYNDROME;

EID: 67649866064     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228072     Document Type: Article

References (51)

1. Cersimo E, Garlick P, Ferretti J: Insulin regulation of renal glucose metabolism in humans. Am J Physiol 1999;276:E78-E84. (Pubitemid 29065596)
2. Alvestrand A: Carbohydrate and insulin metabolism in renal failure. Kidney Int 1997;52(suppl 62):S48-S52. (Pubitemid 27489403)
3. Feneberg R, Sparber M, Veldhuis JD, Mehls O, Ritz E, Schaefer F: Altered temporal organization of plasma insulin oscillations in chronic renal failure. J Clin Endocrinol Metab 2002;87:1965-1973. (Pubitemid 34521475)
4. Andreas F, D'Agostino R, Howard G, Mykkanen I, Russel T, Haffner S: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. (Pubitemid 30430551)
5. KrusinováE, KlementováM, Kopecký J, Wohl P, KazdováL, Mlejnek P, Pravenec M, Hill M, PelikánováT: Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects. Eur J Endocr 2007;157:443-449. (Pubitemid 350018447)
6. Lely AT, Krikken JA, Bakker SJ, Boomsma F, Dullaart RP, Wolffenbuttel BH, Navis G: Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. Clin Endocrinol Metab 2007;92:1821-1826. (Pubitemid 46997195)
7. Meier U, Gresssner AM: Endocrine and regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004;50:1511-1525. (Pubitemid 39121218)
8. Berg AH, Combs TP, Scherer PE: ACRP 30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;12:84-89.
9. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita SH, Takuya Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Toshiaki Ohteki T, Shoko Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-769. (Pubitemid 36735700)
10. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. (Pubitemid 32756432)
11. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y: Adiponectin reduces atherosclerosis in apolipoprotein E deficient mice. Circulation 2002;106:2767-2770. (Pubitemid 35396973)
12. Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L: Disulfide-dependent multimeric assembly of resistin family hormones. Science 2004;304:1154-1158. (Pubitemid 38661851)
13. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator activated receptor- kappa action in humans. Diabetes 2001;50:2199-2202. (Pubitemid 33641901)
14. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 2001;409:307-312. (Pubitemid 32151228)
15. Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler J, Richart C: Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004;12:962-971. (Pubitemid 41202398)
16. Amici G, Orrasch M, Da Rin G, Bocci C: Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001;17:80-83.
17. Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C: Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 2000;36:811-881. (Pubitemid 30747395)
18. Furth SL, Stablein D, Fine RN, Power NR, Fivush BA: Adverse clinical outcomes associated with short stature at dialysis initiation: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatrics 2002;109:909-913. (Pubitemid 34493361)
19. Mak RH, Cheung W, Cone RD, Marks DL: Mechanisms of disease: cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2006;2:527-534. (Pubitemid 44325964)
20. Trayhurn P, Bing C, Wood IS: Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr 2006;136:1935S-1939S. (Pubitemid 43973602)
21. Tokumura M, Nanri S, Kimura K, Tanaka T, Fujita H: Height-specific body mass index reference curves for Japanese children and adolescents 5-17 years of age. Pediatr Int 2004;46:525-530. (Pubitemid 39423195)
22. Lejarraga H, Anisgstein C: Desviaciones estándar del peso para la edad de los estandares argentinos desde el nacimiento hasta la madurez. Arch Argent Pediatr 1992;90:239-242.
23. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170-179.
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576.
25. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing. Diabetes Care 1999;22:1462-1470.
26. Schwartz GJ, Haycock GB, Spitzer A: Plasma creatinine and urea concentration in children. J Pediatr 1976;88:828-832.
27. Mark RHK, DeFronzo RA: Glucose and insulin metabolism in uremia. Nephron 1992;61:377-382.
28. Parra A, Lopez-Uriarte A, Argote RM, Garcia G, Ledon S, Santos D: Effect of hemodialysis on glucose tolerance in children with chronic renal failure. Arch Invest Med (Mex) 1979;10:39-52. (Pubitemid 9190944)
29. Lai HL, Kartal J, Mitsnefes M: Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-α. Pediatr Nephrol 2007;22:1751-1756. (Pubitemid 47337431)
30. Gillerot G, Devuyst O: Molecular mechanisms modifying the peritoneal membrane exposed to peritoneal dialysis. Clin Nephrol 2003;60:1-6. (Pubitemid 36889546)
31. DeFronzo RA, Tobin JD, Rowe JW, Andres R: Glucose intolerance in uremia. Quantification of pancreatic β-cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978;63:425-435.
32. Mark RHK: Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1995;40:304-308.
33. Delaure J, Maingourd C, Couet C, Vidal S, Begros P, Lamisse F: Effect of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects. Perit Dial Int 1998;18:505-511. (Pubitemid 28550352)
34. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005;16:1091-1098. (Pubitemid 41710320)
35. Huang JW, Yen CH J, Chiang HW, Hung KY, Tsai TJ, Wu KD: Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004;43:1047-1055.
36. Guebr-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D: Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005;20:129-134. (Pubitemid 40207617)
37. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-3819. (Pubitemid 32755982)
38. Housova J, Anderlova K, KrizováJ, Haluzikova D, Kremen J, KimstyrováT, PapezováH, Haluzik M: Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J Clin Endocrinol Metab 2005;90:1366-1370. (Pubitemid 40463989)
39. Castaneda-Sceppa C, Sarnak MJ, Wang X, Greene T, Madero M, Kusek JW, Beck G, Kopple JD, Levey AS, Menon V: Role of adipose tissue in determining muscle mass in patients with chronic kidney disease. J Ren Nutr 2007;17:314-322. (Pubitemid 47284908)
40. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001;98:2005-2010. (Pubitemid 32165613)
41. Nova E, Samartin S, Gomez S, Morande G, Marcos A: The adaptive response of the immune system to the particular malnutrition of eating disorders. Eur J Clin Nutr 20002;56(suppl 3):S34-S37.
42. Saito K, Arata S, Hosono T, Sano Y, Takahashi K, Choi-Miura NH, Nakano Y, Tobe T, Tomita M: Adiponectin plays an important role in efficient energy usage under energy shortage. Biochim Biophys Acta 2006;1761:709-716. (Pubitemid 44108745)
43. Chudek J, Adamczak M, Karkoszka H, Budziński G, Ignacy W, Funahashi T, Matsuzawa Y, Cierpka L, Kokot F, Wiecek A: Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc 2003;35:2186-2189. (Pubitemid 37194359)
44. Shen YY, Charlesworth JA, Kelly JJ, Peake PW: The effect of renal transplantation on adiponectin and its isoforms and receptors. Metabolism 2007;56:1201-1208. (Pubitemid 47223259)
45. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749.
46. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR κ activators. Biochem Biophys Res Commun 2003;300:472-476. (Pubitemid 38375833)
47. Way JM, Gorgun CZ, Tong Q, Uysal KT, Brown KK, Harrington WW, Oliver WR, Wilson TM, Kliewer SA, Hotamisligi GS: Adipose tissue resistin proliferator-activated receptor-γ agonists. J Biol Chem 2001;276:25651-25653.
48. Schäffer A, Büchler C, Müller-Ladner U: Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm Metab Res 2004;36:702-707. (Pubitemid 39486971)
49. Heilbronn LK, Rood J, Janderova L, Albu J B, Kelley DE, Ravussin E, Smith SR: Relationship between serum resistin concentrations and insulin resistance in nonobese, obese and obese diabetic subjects. J Clin Endocrinol Metab 2004;89:1844-1848. (Pubitemid 38507943)
50. Kielstein JT, Becker B, Graf S, Brabat G, Haller H, Fliser D: Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003;42:62-66. (Pubitemid 36807655)
51. Nüsken KD, Kratzsch J, Wienholz V, Stöhr W, Rascher W, Dötsch J: Circulating resistin concentrations in children depend on renal function. Nephrol Dial Transplant 2006;21:107-112.